Login
Streaming News
Register
Menu
Subscribe
Podcast
Streaming News
Most Active
About Us
List Of OTC Companies
OTC Pink
OTCQB
OTCQX
Close Menu
Special Research Report
HOW TO USE DISCUSSION BOARDS
Office Hours: 9:00 AM - 4:00 PM (EST) Monday - Thursday Call:
602-821-1102
Featured News
EVFM
Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
Washington State HCA Removes Prior Authorization for Hormone-Free “In the Moment” Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Game
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor
Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi
Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value
Evofem’s Phexxi Contraceptive Gel to be Offered by Female Telehealth Leader Favor (Formerly The Pill Club)
EVFM
Quote
|
News
|
Filings
|
Discuss
0
Discussion
EVFM
Login
-or-
Register
to join the discussion.
X
Search
Generic filters
Hidden label
Hidden label
Hidden label
Hidden label